Association between neoadjuvant paclitaxel dose intensity and outcomes in early triple-negative and HER2-positive breast cancer: a real-world data analysis
新辅助紫杉醇剂量强度与早期三阴性及HER2阳性乳腺癌预后的关系:一项真实世界数据分析
期刊:
影响因子:
doi:10.1016/j.esmorw.2025.100158
van Marcke, C; Pogoda, K; Fenton, H; Vallet, M; Plavc, G; Borges, M; Yousuf, H; Dumas, E; Berliere, M; Ciliberto, G; Duhoux, F P; Fano, V; Hall, P; Kolenc Mokotar, K; Lopes Conceicao, L; Pereira, F; Škoporc, A; Thomas, A; Tramonti, G; van Bockstal, M R; Vici, P; Uher, M; Krasniqi, E